Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diacerein

C M Spencer1, M I Wilde

  • 1Adis International Limited, Auckland, New Zealand. demail@adis.co.nz

Drugs
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Diacerein, an osteoarthritis treatment, reduces cartilage damage by inhibiting interleukin-1 activity. Clinical trials show it improves pain and joint function, with diarrhea as the main side effect.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modafinil : A Review of its Pharmacology and Clinical Efficacy in the Management of Narcolepsy.

CNS drugs·2016
Same author

Quetiapine : A Review of its Use in Schizophrenia.

CNS drugs·2016
Same author

The authors' reply.

PharmacoEconomics·2016
Same author

Mirtazapine : A Review of its Pharmacology and Therapeutic Potential in the Management of Major Depression.

CNS drugs·2015
Same author

The Yin and Yang of inflammation.

Current molecular medicine·2014
Same author

Lymphotoxin beta receptor signaling limits mucosal damage through driving IL-23 production by epithelial cells.

Mucosal immunology·2014
Same journal

Botulinum Toxin Type A for Trigeminal and Postherpetic Neuralgia: An Umbrella Review of Systematic Reviews.

Drugs·2026
Same journal

Biologics and Small Molecule Inhibitors: Novel Therapeutic Strategies for Cutaneous Adverse Drug Reactions.

Drugs·2026
Same journal

Use of Sedative-Hypnotic Drugs and the Risk of Developing Alzheimer's Disease: A Systematic Review, Meta-Analysis and Meta-Regression.

Drugs·2026
Same journal

Relacorilant: First Approval.

Drugs·2026
Same journal

Developmental Progress and Future Potential for Inhaled Biologics in the Treatment of Respiratory Diseases.

Drugs·2026
Same journal

Linerixibat: First Approval.

Drugs·2026
See all related articles

Area of Science:

  • Pharmacology
  • Immunology
  • Rheumatology

Background:

  • Diacerein is a prodrug, with its active metabolite Rhein inhibiting interleukin-1 (IL-1).
  • IL-1 plays a key role in the pathogenesis of osteoarthritis (OA) by stimulating collagenase production in articular cartilage.
  • Rhein also exhibits anti-inflammatory and immunomodulatory effects by inhibiting neutrophil and macrophage functions.

Purpose of the Study:

  • To evaluate the efficacy and safety of diacerein in patients with osteoarthritis.
  • To assess the impact of diacerein on articular cartilage damage and inflammatory markers.
  • To compare diacerein with non-steroidal anti-inflammatory drugs (NSAIDs) in OA treatment.

Main Methods:

  • Animal models of osteoarthritis were used to assess cartilage damage.

Related Experiment Videos

  • In vitro studies investigated the effects of Rhein on neutrophil and macrophage activity.
  • Clinical trials evaluated diacerein's efficacy (pain scores, joint function) and safety (adverse effects) in OA patients over 6 months.
  • Comparative trials assessed diacerein's efficacy against NSAIDs over 2 months.

    • Main Results:

    • Diacerein reduced articular cartilage damage in animal OA models.
    • Rhein dose-dependently inhibited inflammatory cell functions, including superoxide anion production and migration.
    • Clinical trials demonstrated significant improvement in pain and joint function in 57-85% of OA patients treated with diacerein.
    • Diacerein showed comparable efficacy to NSAIDs, albeit with a slower onset of action.
    • The primary adverse effect reported was diarrhea.

    Conclusions:

    • Diacerein effectively reduces inflammation and cartilage degradation in osteoarthritis.
    • Oral diacerein demonstrates significant clinical benefits in pain relief and joint function improvement for OA patients.
    • Diacerein is a viable treatment option for osteoarthritis, with a generally favorable safety profile, though gastrointestinal side effects like diarrhea should be monitored.